KalVista Pharmaceuticals Long Term Deferred Assets (Quarterly) Trends

KalVista Pharmaceuticals, Inc. (KALV)

15.31 +0.71 (+4.86%) USD | NASDAQ | Jan 20, 16:00

15.29 -0.02 (-0.13%) Pre-Market: 08:58

View Long Term Deferred Assets (Quarterly) for KALV.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

BioCryst Pharmaceuticals, Inc.	--
Silvergate Capital Corp.	--
Perspective Therapeutics, Inc.	--
Electromed, Inc.	Upgrade
InfuSystem Holdings, Inc.	Upgrade